Publication:
Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

Simple item page
dc.contributor.authorPusuroglu, Hamdi
dc.contributor.authorAkgul, Ozgur
dc.contributor.authorErturk, Mehmet
dc.contributor.authorUyarel, Huseyin
dc.contributor.authorBulut, Umit
dc.contributor.authorAkkaya, Emre
dc.contributor.authorButurak, Ali
dc.contributor.authorSurgit, Ozgur
dc.contributor.authorFuat, Ali
dc.contributor.authorYildirim, Aydin
dc.date.accessioned2020-10-22T20:21:50Z
dc.date.available2020-10-22T20:21:50Z
dc.date.issued2014-11-01T00:00:00Z
dc.description.abstractObjectives The aim of this study was to evaluate the prognostic value of soluble CD40 ligand (sCD40L) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing a primary percutaneous coronary intervention (PCI).
dc.identifier.citationPusuroglu H., Akgul O., Erturk M., Uyarel H., Bulut U., Akkaya E., Buturak A., Surgit O., Fuat A., ÇETİN M., et al., -Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction-, CORONARY ARTERY DISEASE, cilt.25, ss.558-564, 2014
dc.identifier.doi10.1097/mca.0000000000000142
dc.identifier.pubmed25004238
dc.identifier.scopus84927692146
dc.identifier.urihttp://hdl.handle.net/20.500.12645/24713
dc.identifier.wosWOS:000343123400005
dc.titlePredictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction
dc.typeArticle
dspace.entity.typePublication
local.avesis.idde824c29-82f0-4f01-bf6e-18aacd2d053b
local.publication.isinternational1
Files
Collections
Yayınlar - Eserler